Abraham Ceesay, CEO: Rapport Therapeutics RAPP Sell · Filed 01/22

Trade details

Type: Insider sale
Amount: $152,357.96
Shares · price: 5,833 sh · $26.12 a share
Held after: 562,080 sh
Stock: Rapport Therapeutics RAPP
Person: Abraham CeesayCEO
Trade date: 26/01/20
Filed: 26/01/22
Days to filing: 2 days

Sold 1.0% of holdings

Share of holding sold: 1.0%

Rapport Therapeutics trades, last 26 weeks

What else happened in Rapport Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/21~02/19

Abraham Ceesay's recent trades

Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$76.2K
1,952 sh
$76.2K
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$8,570
215 sh
$8,570
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$1,765
43 sh
$1,765
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$4M
99,480 sh
$4M
Filed 06/29
Traded 06/29
Abraham CeesayDirector
Planned salePacira BioSciences
Planned sale
Pacira BioSciences
PCRX
$210.4K
9,039 sh
$210.4K
Filed 06/12
Traded 06/12